Insufficient Data
Stock has been generating better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Pro Only
Pro Only
Pro Only
Strides Pharma Science is a vertically integrated global pharmaceutical company engaged in the development and manufacturing of active pharmaceutical ingredients and formulations, as well as biotech
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has increased by 1.00%
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has decreased by 2.46%
5 days ago•Financial Express
1 week ago•Business Standard
1 month ago•Business Standard
Strides Pharma Science Limited has informed the Exchange about press release dated 15-May-2022 titled Clarification on news item appeared online based on a report filed by Press Trust of India (PTI) titled ¬タワUnable to sell Sputnik Light stock, Stelis Biopharma requests PM Modi for procurement of jabs.¬タン | Download
Strides Pharma Science Limited has informed the Exchange about press release dated 15-May-2022 titled Clarification on news item appeared online based on a report filed by Press Trust of India (PTI) titled ¬タワUnable to sell Sputnik Light stock, Stelis Biopharma requests PM Modi for procurement of jabs.¬タン | Download
Final • Div/Share: ₹ 2.5
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data